Genetic Factors Associated with a Poor Outcome in Head and Neck Cancer Patients Receiving Definitive Chemoradiotherapy

About half of advanced stage head and neck squamous cell carcinoma (HNSCC) patients can be cured by chemoradiotherapy. Patient outcome may be partially determined by the genetic alterations in HNSCC, rendering these alterations promising candidate prognostic factors and/or therapeutic targets. Howev...

Descripción completa

Detalles Bibliográficos
Autores principales: Vossen, David M., Verhagen, Caroline V.M., van der Heijden, Martijn, Essers, Paul B.M., Bartelink, Harry, Verheij, Marcel, Wessels, Lodewyk F.A., van den Brekel, Michiel W.M., Vens, Conchita
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521057/
https://www.ncbi.nlm.nih.gov/pubmed/30934880
http://dx.doi.org/10.3390/cancers11040445

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6521057/
https://www.ncbi.nlm.nih.gov/pubmed/30934880
http://dx.doi.org/10.3390/cancers11040445

Ejemplares similares